FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2107803653> ?p ?o ?g. }

• W2107803653 endingPage "638" @default.
• W2107803653 startingPage "628" @default.
• W2107803653 abstract "Objectives: This study aims to systematically identify and summarize the effects of antifungal prophylaxis in non-neutropenic critically ill adult patients on all-cause mortality and the incidence of invasive fungal infections. Methods: Systematic review and meta-analysis of randomized controlled trials in all languages comparing the prophylactic use of any antifungal agent or regimen with placebo, no antifungal or another antifungal agent or regimen in non-neutropenic critically ill adult patients. We searched the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, Issue 3, 2005), MEDLINE (1966 to 2 September 2005) and EMBASE (1980 to week 36, 2005). We also hand-searched reference lists, abstracts of conference proceedings and scientific meetings (1998–2004) and contacted authors of included studies and pharmaceutical manufacturers. The primary outcomes assessed were all-cause mortality and proven invasive fungal infections. Two reviewers independently applied selection criteria, performed quality assessment and extracted data using an intention-to-treat approach. Data were synthesized using the random effects model and expressed as relative risk with 95% confidence intervals. Results: Twelve unique trials (eight comparing fluconazole and four ketoconazole with no antifungal or a non-absorbable agent) involving 1606 randomized patients were included. For both outcomes of total mortality and invasive fungal infections, almost all trials of fluconazole and ketoconazole separately showed a non-significant risk reduction with prophylaxis. When combined, fluconazole/ketoconazole reduced total mortality by one-quarter (relative risk 0.76, 95% confidence interval 0.59–0.97) and invasive fungal infections by about one-half (relative risk 0.46, 95% confidence interval 0.31–0.68). No significant increase in the incidence of infection or colonization with the azole-resistant fungal pathogens Candida glabrata or Candida krusei was demonstrated, although the confidence intervals of the summary effect measures were wide. Adverse effects requiring treatment discontinuation were not more common amongst patients receiving prophylaxis. Results across all trials were homogeneous despite considerable heterogeneity in clinical and methodological characteristics. Conclusions: Prophylaxis with fluconazole or ketoconazole in critically ill patients reduces invasive fungal infections by one-half and total mortality by one-quarter. Although no significant increase in azole-resistant Candida species associated with prophylaxis was demonstrated, trials were not powered to exclude such an effect. In patients at increased risk of invasive fungal infections, antifungal prophylaxis with fluconazole should be considered." @default.
• W2107803653 created "2016-06-24" @default.
• W2107803653 creator A5022370216 @default.
• W2107803653 creator A5038938109 @default.
• W2107803653 creator A5039063558 @default.
• W2107803653 creator A5039834479 @default.
• W2107803653 date "2006-02-03" @default.
• W2107803653 modified "2023-10-16" @default.
• W2107803653 title "Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials" @default.
• W2107803653 cites W1836488607 @default.
• W2107803653 cites W1949218306 @default.
• W2107803653 cites W1963818949 @default.
• W2107803653 cites W1974437406 @default.
• W2107803653 cites W1976941151 @default.
• W2107803653 cites W1979066895 @default.
• W2107803653 cites W1979297402 @default.
• W2107803653 cites W1979708960 @default.
• W2107803653 cites W1982563736 @default.
• W2107803653 cites W1996225900 @default.
• W2107803653 cites W2000724121 @default.
• W2107803653 cites W2013094738 @default.
• W2107803653 cites W2015008429 @default.
• W2107803653 cites W2021610658 @default.
• W2107803653 cites W2028568769 @default.
• W2107803653 cites W2031686290 @default.
• W2107803653 cites W2035238837 @default.
• W2107803653 cites W2037167636 @default.
• W2107803653 cites W2037224917 @default.
• W2107803653 cites W2053017331 @default.
• W2107803653 cites W2063847223 @default.
• W2107803653 cites W2063951746 @default.
• W2107803653 cites W2064476714 @default.
• W2107803653 cites W2071756060 @default.
• W2107803653 cites W2081837357 @default.
• W2107803653 cites W2083239670 @default.
• W2107803653 cites W2095696028 @default.
• W2107803653 cites W2103915504 @default.
• W2107803653 cites W2105124717 @default.
• W2107803653 cites W2114509444 @default.
• W2107803653 cites W2125435699 @default.
• W2107803653 cites W2133328722 @default.
• W2107803653 cites W2135175273 @default.
• W2107803653 cites W2138866758 @default.
• W2107803653 cites W2139728976 @default.
• W2107803653 cites W2144495358 @default.
• W2107803653 cites W2157766752 @default.
• W2107803653 cites W2157823046 @default.
• W2107803653 cites W2164404625 @default.
• W2107803653 cites W2166075607 @default.
• W2107803653 cites W2169453316 @default.
• W2107803653 cites W2169552905 @default.
• W2107803653 cites W2183369663 @default.
• W2107803653 cites W4214559180 @default.
• W2107803653 cites W4245595809 @default.
• W2107803653 cites W4248053214 @default.
• W2107803653 cites W4317527935 @default.
• W2107803653 doi "https://doi.org/10.1093/jac/dki491" @default.
• W2107803653 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16459344" @default.
• W2107803653 hasPublicationYear "2006" @default.
• W2107803653 type Work @default.
• W2107803653 sameAs 2107803653 @default.
• W2107803653 citedByCount "137" @default.
• W2107803653 countsByYear W21078036532012 @default.
• W2107803653 countsByYear W21078036532013 @default.
• W2107803653 countsByYear W21078036532014 @default.
• W2107803653 countsByYear W21078036532015 @default.
• W2107803653 countsByYear W21078036532016 @default.
• W2107803653 countsByYear W21078036532017 @default.
• W2107803653 countsByYear W21078036532018 @default.
• W2107803653 countsByYear W21078036532019 @default.
• W2107803653 countsByYear W21078036532020 @default.
• W2107803653 countsByYear W21078036532021 @default.
• W2107803653 countsByYear W21078036532022 @default.
• W2107803653 crossrefType "journal-article" @default.
• W2107803653 hasAuthorship W2107803653A5022370216 @default.
• W2107803653 hasAuthorship W2107803653A5038938109 @default.
• W2107803653 hasAuthorship W2107803653A5039063558 @default.
• W2107803653 hasAuthorship W2107803653A5039834479 @default.
• W2107803653 hasConcept C120665830 @default.
• W2107803653 hasConcept C121332964 @default.
• W2107803653 hasConcept C126322002 @default.
• W2107803653 hasConcept C142724271 @default.
• W2107803653 hasConcept C156957248 @default.
• W2107803653 hasConcept C16005928 @default.
• W2107803653 hasConcept C168563851 @default.
• W2107803653 hasConcept C177713679 @default.
• W2107803653 hasConcept C204787440 @default.
• W2107803653 hasConcept C27081682 @default.
• W2107803653 hasConcept C2776478404 @default.
• W2107803653 hasConcept C2779548794 @default.
• W2107803653 hasConcept C2779629538 @default.
• W2107803653 hasConcept C2780651595 @default.
• W2107803653 hasConcept C2781064554 @default.
• W2107803653 hasConcept C2781413609 @default.
• W2107803653 hasConcept C44249647 @default.
• W2107803653 hasConcept C61511704 @default.
• W2107803653 hasConcept C71924100 @default.
• W2107803653 hasConcept C82789193 @default.

• next